siRNA-mediated knockdown of Pdcd4 expression causes upregulation of p21(Waf1/Cip1) expression

Oncogene

Volumn 27, Issue 35, 2008, Pages 4820-4829

  Bitomsky, N ^a   Wethkamp, N ^a   Marikkannu, R ^a   Klempnauer, K H ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

DNA damage response; p21(Waf1 Cip1); p53; Pdcd4; siRNA

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1; PROGRAMMED CELL DEATH PROTEIN 4; PROTEIN P53; SHORT HAIRPIN RNA; SMALL INTERFERING RNA; TUMOR SUPPRESSOR PROTEIN;

APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL FATE; CELL SURVIVAL; CONTROLLED STUDY; DNA DAMAGE; DOWN REGULATION; EXPERIMENTAL MODEL; FEMALE; GENE ACTIVATION; GENE EXPRESSION REGULATION; GENE FUNCTION; HELA CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; RNA INTERFERENCE; TUMOR GENE; ULTRAVIOLET IRRADIATION; UPREGULATION;

ACETYLATION; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DNA DAMAGE; HELA CELLS; HUMANS; PROMOTER REGIONS (GENETICS); RNA, SMALL INTERFERING; RNA-BINDING PROTEINS; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION;

EID: 49649102818     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2008.115     Document Type: Article

References (62)

1. Afonja O, Juste D, Das S, Matsuhashi S, Samuels HH. (2004). Induction of PDCD4 tumor suppressor gene expression by RAR agonists, antiestrogen and HER-2/neu antagonist in breast cancer cells. Evidence for a role in apoptosis. Oncogene 23: 8135-8145.
2. Bendjennat M, Boulaire J, Jascur T, Brickner H, Barbier V, Sarasin A et al. (2003). UV irradiation triggers ubiquitin-dependent degradation of p21(WAF1) to promote DNA repair. Cell 114: 599-610.
3. Biankin AV, Kench JG, Morey AL, Lee CS, Biankin SA, Head DR et al. (2001). Overexpression of p21(WAF1/CIP1) is an early event in the development of pancreatic intraepithelial neoplasia. Cancer Res 61: 8830-8837.
4. Bitomsky N, Böhm M, Klempnauer K-H. (2004). Transformation suppressor protein Pdcd4 interferes with JNK-mediated phosphorylation of c-Jun and recruitment of the coactivator p300 by c-Jun. Oncogene 23: 7484-7493.
5. Bode AM, Dong Z. (2004). Post-translational modification of p53 in tumorigenesis. Nat Rev Cancer 4: 793-805.
6. Böhm M, Sawicka K, Siebrasse JP, Brehmer-Fastnacht A, Peters R, Klempnauer K-H. (2003). The transformation suppressor protein Pdcd4 shuttles between nucleus and cytoplasm and binds RNA. Oncogene 22: 4905-4910.
7. Burk O, Mink S, Ringwald M, Klempnauer K-H. (1993). Synergistic activation of the chicken mim-1 gene by v-myb and C/EBP transcription factors. EMBO J 12: 2027-2038.
8. Chen Y, Knosel T, Kristiansen G, Pietas A, Garber ME, Matsuhashi S et al. (2003). Loss of PDCD4 expression in human lung cancer correlates with tumour progression and prognosis. J Pathol 200: 640-646.
9. Cmarik JL, Min H, Hegamyer G, Zhan S, Kulesz-Martin M, Yoshinaga H et al. (1999). Differentially expressed protein Pdcd4 inhibits tumor promoter-induced neoplastic transformation. Proc Natl Acad Sci USA 96: 14037-14042.
10. Dorrello NV, Peschiaroli A, Guardavaccaro D, Colburn NH, Sherman NE, Pagano M. (2006). S6K1- and βTRCP-mediated degradation of Pdcd4 promotes protein translation and cell growth. Science 314: 467-471.
11. Dupont J, Karas M, LeRoith D. (2003). The cyclin-dependent kinase inhibitor p21CIP/WAF is a positive regulator of insulin-like growth factor I-induced cell proliferation in MCF-7 human breast cancer cells. J Biol Chem 278: 37256-37264.
12. El-Deiry WS, Tokino T, Velculesco VE, Levy DB, Parsons R, Trent JM et al. (1993). WAF1, a potential mediator of p53 tumor suppression. Cell 75: 817-825.
13. Erber R, Klein W, Andl T, Enders C, Born AI, Conradt C et al. (1997). Aberrant p21(CIP1/WAF1) protein accumulation in head and neck cancer. Int J Cancer 74: 383-389.
14. Fan Y, Borowsky AD, Weiss RH. (2003). An antisense oligodeoxynucleotide to p21(Waf1/Cip1) causes apoptosis in human breast cancer cells. Mol Cancer Ther 2: 773-782.
15. Fornace Jr AJ, Alamo Jr I, Hollander MC. (1988). DNA damage-inducible transcripts in mammalian cells. Proc Natl Acad Sci USA 85: 8800-8804.
16. Gao F, Zhang P, Zhou C, Li J, Wang Q, Zhu F et al. (2007). Frequent loss of PDCD4 expression in human glioma: possible role in the tumorigenesis of glioma. Oncol Rep 17: 123-128.
17. Gartel AL, Radhakrishnan SK. (2005). Lost in transcription: p21 repression, mechanisms, and consequences. Cancer Res 65: 3980-3985.
18. Göke A, Göke R, Knolle A, Trusheim H, Schmidt H, Wilmen A et al. (2002). DUG is a novel homologue of translation initiation factor 4G that binds eIF4A. Biochem Biophys Res Commun 297: 78-82.
19. Göke R, Barth P, Schmidt A, Samans B, Lankat-Buttgereit B. (2004). Programmed cell death protein 4 suppresses CDK1/cdc2 via induction of p21(Waf1/Cip1). Am J Physiol Cell Physiol 287: C1541-C1546.
20. Gorospe M, Cirielli C, Wang X, Seth P, Capogrossi MC, Holbrook NJ. (1997). p21(Waf1/Cip1) protects against p53-mediated apoptosis of human melanoma cells. Oncogene 14: 929-935.
21. Gu W, Roeder RG. (1997). Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell 90: 595-606.
22. Harper JW, Adami GR, Wei N, Keymarsi K, Elledge S. (1993). The p21 Cdk interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75: 805-816.
23. Herold S, Wanzel M, Beuger V, Frohme C, Beul D, Hillukkala T et al. (2002). Negative regulation of the mammalian UV response by Myc through association with Miz-1. Mol Cell 10: 509-521.
24. Hershey JWB, Merrick WC. (2000). Translational control of gene expression: pathway and mechanism of initiation of protein synthesis. In: Sonenberg N, Hershey JWB, Mathews MB (eds). Translational Control. Cold Spring Harbor Laboratory Press: Cold Spring Harbor, New York, pp 33-88.
25. Hilliard A, Hilliard B, Zheng SJ, Sun H, Miwa T, Song W et al. (2006). Translational regulation of autoimmune inflammation and lymphoma genesis by programmed cell death 4. J Immunol 177: 8095-8102.
26. Jansen AP, Camalier CE, Colburn NH. (2005). Epidermal expression of the translation inhibitor programmed cell death 4 suppress es tumorigenesis. Cancer Res 65: 6034-6041.
27. Jansen AP, Camalier CE, Stark C, Colburn NH. (2004). Characterization of programmed cell death 4 in multiple human cancers reveals a novel enhancer of drug sensitivity. Mol Cancer Ther 3: 103-110.
28. Jung JM, Bruner JM, Ruan S, Langford LA, Kyritsis AP, Kobayashi T et al. (1995). Increased levels of p21WAF1/Cip1 in human brain tumors. Oncogene 11: 2021-2028.
29. LaBaer J, Garrett MD, Stevenson LF, Slingerland JM, Sandhu C, Chou HS et al. (1997). New functional activities for the p21 family of CDK inhibitors. Genes Dev 11: 847-862.
30. Lankat-Buttgereit B, Göke R. (2003). Programmed cell death protein 4 (pdcd4): a novel target for antineoplastic therapy? Biol Cell 95: 515-519.
31. LaRonde-LeBlanc N, Santhanam AN, Baker AR, Wlodawer A, Colburn NH. (2007). Structural basis for inhibition of translation by the tumor suppressor Pdcd4. Mol Cell Biol 27: 147-156.
32. Linder P, Lasko P, Ashburner M, Leroy P, Nielsen P, Nishi K et al. (1989). Birth of the D-E-A-D box. Nature 337: 121-122.
33. Martoriati A, Doumont G, Alcalay M, Bellefroid E, Pelicci PG, Marine JC. (2005). Dapk1, encoding an activator of a p19ARF-p53-mediated apoptotic checkpoint, is a transcription target of p53. Oncogene 24: 1461-1466.
34. Moscovici C, Moscovici MG, Jimenez H, Lai MM, Hayman MJ, Vogt PK. (1977). Continuous tissue culture cell lines derived from chemically induced tumors of Japanese quail. Cell 11: 95-103.
35. Mudduluru G, Medved F, Grobholz R, Jost C, Gruber A, Leupold JH et al. (2007). Loss of programmed cell death 4 expression marks adenoma-carcinoma transition, correlates inversely with phosphorylated protein kinase B, and is an independent prognostic factor in resected colorectal cancer. Cancer 110: 1697-1707.
36. Ozanne BW, Spence HJ, McGarry LC, Hennigan RF. (2007). Transcription factors control invasion: AP-1 the first among equals. Oncogene 26: 1-10.
37. Palamarchuk A, Efanov A, Maximov V, Aqeilan RI, Croce CM, Pekarsky Y. (2005). Akt phosphorylates and regulates Pdcd4 tumor suppressor protein. Cancer Res 65: 11282-11286.
38. Prives C, Manley JL. (2001). Why is p53 acetylated? Cell 107: 815-818.
39. Rozen F, Edery I, Meerovitch K, Dever T, Merrick W, Sonenberg N. (1990). Bidirectional RNA helicase activity of eukaryotic translation initiation factor 4A and 4F. Mol Cell Biol 10: 1134-1144.
40. Seoane J, Le HV, Massague J. (2002). Myc suppression of the p21(Cip1) Cdk inhibitor influences the outcome of the p53 response to DNA damage. Nature 419: 729-734.
41. Schlichter U, Burk O, Worpenberg S, Klempnauer K-H. (2001). The chicken Pdcd4 gene is regulated by v-Myb. Oncogene 20: 231-239.
42. Sherr CJ, Roberts JM. (1999). CDK inhibitors: positive and negative regulators of the G1-phase progression. Genes Dev 13: 1501-1512.
43. Shibahara K, Asano M, Ishida Y, Aoki T, Koike T, Honjo T. (1995). Isolation of a novel mouse gene MA-3 that is induced upon programmed cell death. Gene 166: 297-301.
44. Sohn D, Essmann F, Schulze-Osthoff K, Jänicke RU. (2006). p21 blocks irradiation-induced apoptosis downstream of mitochondria by inhibition of cyclin-dependent kinase-mediated caspase-9 activation. Cancer Res 66: 11254-11262.
45. Toledo F, Wahl GM. (2006). Regulating the p53 pathway: in vitro hypotheses, in vivo veritas. Nat Rev Cancer 6: 909-923.
46. van de Wetering M, Oving I, Muncan V, Pon Fong MT, Brantjes H, van Leenen D et al. (2003). Specific inhibition of gene expression using a stably integrated, inducible small-interfering-RNA vector. EMBO Rep 4: 609-615.
47. Wang Q, Sun Z, Yang H-S. (2008). Downregulation of tumour suppressor Pdcd4 promote s invasion and activates both β-catenin/TCF and AP-1-dependent transcription in colon carvinoma cells. Oncogene 27: 1527-1535.
48. Waters LC, Boehm M, Veverka V, Muskett FW, Frenkiel TA, Kelly GP et al. (2006). NMR assignment and secondary structure determination of the C-terminal MA-3 domain of the tumour suppressor protein Pdcd4. J Biomol NMR 36(Suppl 1): 18.
49. Waters LC, Veverka V, Boehm M, Schmedt T, Choong PT, Muskett FW et al. (2007). Structure of the C-terminal MA-3 domain of the tumour suppressor protein Pdcd4 and characterisation of its interaction with eIF4A. Oncogene 26: 4941-4950.
50. Weiss RH. (2003). p21Waf1/Cip1 as a therapeutic target in breast and other cancers. Cancer Cell 4: 425-429.
51. Weiss RH, Marshall D, Howard L, Corbacho AM, Cheung AT, Sawai ET. (2003). Suppression of breast cancer growth and angiogenesis by an antisense oligodeoxynucleotide to p21(Waf1/Cip1). Cancer Lett 189: 39-48.
52. Wen YH, Shi X, Chiriboga L, Matsahashi S, Yee H, Afonja O. (2007). Alterations in the expression of PDCD4 in ductal carcinoma of the breast. Oncol Rep 18: 1387-1393.
53. Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R, Beach D. (1993). p21 is a universal inhibitor of cyclin kinases. Nature 366: 701-704.
54. Yang HS, Cho MH, Zacowicz H, Hegamyer G, Sonenberg N, Colburn N. (2004). A novel function of the MA-3 domains in transformation and translation suppressor Pdcd4 is essential for its binding to eukaryotic translation initiation factor 4A. Mol Cell Biol 24: 3894-3906.
55. Yang HS, Jansen AP, Komar AA, Zheng X, Merrick WC, Costes S et al. (2003a). The transformation suppressor Pdcd4 is a novel eukaryotic translation initiation factor 4A binding protein that inhibits translation. Mol Cell Biol 23: 26-37.
56. Yang HS, Jansen AP, Nair R, Shibahara K, Verma AK, Cmarik JL et al. (2001). A novel transformation suppressor, Pdcd4, inhibits AP-1 transactivation but not NF-kappaB or ODC transactivation. Oncogene 20: 669-676.
57. Yang HS, Knies JL, Stark C, Colburn NH. (2003b). Pdcd4 suppresses tumor phenotype in JB6 cells by inhibiting AP-1 transactivation. Oncogene 22: 3712-3720.
58. Yang H-S, Matthews CP, Clair T, Wang Q, Baker AR, Li C-CH et al. (2006). Tumorigenesis suppressor Pdcd4 down-regulates mitogen-activated protein kinase kinase kinase kinase 1 expression to suppress colon carcinoma cell invasion. Mol Cell Biol 26: 1297-1306.
59. Yang W, Klos KS, Zhou X, Yao J, Yang Y, Smith TL et al. (2003c). ErbB2 overexpression in human breast carcinoma is correlated with p21Cip1 up-regulation and tyrosine-15 hyperphosphorylation of p34Cdc2: poor responsiveness to chemotherapy with cyclophoshamide methotrexate, and 5-fluorouracil is associated with Erb2 overexpression and with p21Cip1 overexpression. Cancer 98: 1123-1130.
60. Young MR, Yang HS, Colburn NH. (2003). Promising molecular targets for cancer prevention: AP-1, NF-kappa B and Pdcd4. Trends Mol Med 9: 36-41.
61. Zeng YX, Somasundaram K, el-Deiry WS. (1997). AP2 inhibits cancer cell growth and activates p21WAF1/CIP1 expression. Nat Genet 15: 78-82.
62. Zhang H, Ozaki I, Mizuta T, Hamajima H, Yasutake T, Eguchi Y et al. (2006). Involvement of programmed cell death 4 in transforming growth factor-beta1-induced apoptosis in human hepatocellular carcinoma. Oncogene 25: 6101-6112.